Rainbow Rare Earths has significantly simplified the extraction process for its phosphogypsum rare earths recovery project by controlling fluorine with silica and introducing continuous ion exchange. This breakthrough reduces capital and operating costs while improving plant safety and operability. The project recovers rare earths from waste rather than mining ore, focusing on producing high-purity NdPr and heavy rare earths like dysprosium and terbium. The company is finalizing the feasibility study with remaining work on optimizing solvent extraction to ensure product purity and recovery targets.
Cohu is rated a buy due to its strong position in AI and high-performance computing (HPC) chip testing, which is expected to drive significant revenue growth. Management aims for $600–800 million in revenue, 48–50% gross margin, and $1.50–$3.25 non-G...
Hyperliquid has launched a dedicated Layer-1 blockchain designed specifically for perpetual futures trading directly on-chain. This new blockchain removes the need for external bridges and introduces native order-book mechanics that operate within th...
Mirum Pharmaceuticals is rapidly growing as a leader in liver disease treatments, raising its 2026 global sales forecast to $660–$680 million due to strong performance of its drug LIVMARLI. Although recent acquisitions have delayed the company’s cash...
Nigel Farage has been reported to the UK Parliament’s standards watchdog over allegations that he lobbied the Bank of England on cryptocurrency policy in ways that could benefit Christopher Harborne, a major investor in stablecoin issuer Tether who h...
UnitedHealth Group remains a strong long-term investment despite recent operational challenges and price increases. Management targets 13–16% bottom-line growth driven by margin recovery, AI investments, and share buybacks. Current valuations suggest...
